NASDAQ •
Healthcare •
Biotechnology •
Quote as of 05/04/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization2,444.05 mln
Float232 mln
Earnings Date05/06/2026
EPS
0.60
Moderate
P / E
17.18
Moderately valued
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
-0.15
Highly suspicious
1-Year Forecast
20.67
Transformational upside
Relative Strength
21
/ 100
Significantly lagging
Business Description
ADMA Biologics is a U.S.-based company that produces and sells medicines made from human plasma, primarily used to help patients with weakened immune systems or serious infections like Hepatitis B. Founded in 2004 and based in Ramsey, New Jersey, the company runs its own plasma collection centers and manufacturing operations to support its product line. Its treatments reach patients through wholesalers, specialty pharmacies, and distributors across the United States and in other countries.
